tiprankstipranks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market

Bright Minds Biosciences (DRUG) Technical Analysis

Compare
215 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is 1.26, suggesting Bright Minds Biosciences is a Sell.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 39.41, while Bright Minds Biosciences’s (DRUG) share price is $37.4, making it a Sell.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 37.63, while Bright Minds Biosciences’s (DRUG) share price is $37.4, making it a Sell.

Bright Minds Biosciences (DRUG) Pivot Points

Feb 21, 2025, 08:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
31.38
34.44
35.98
39.04
40.58
43.64
45.18
Fibonacci
34.44
36.20
37.29
39.04
40.80
41.89
43.64
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Feb 21, 2025, 08:45 AM
Period
Simple
Exponential
MA5
41.52Sell
40.17Sell
MA10
42.27Sell
40.49Sell
MA20
37.60Sell
39.41Sell
MA50
38.11Sell
37.63Sell
MA100
34.67Buy
32.42Buy
MA200
17.89Buy
20.29Buy
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 40.49, while Bright Minds Biosciences’s (DRUG) share price is $37.4, making it a Sell.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 32.42, while Bright Minds Biosciences’s (DRUG) share price is $37.4, making it a Buy.
Bright Minds Biosciences’s (DRUG) stock price is $37.4 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 38.11, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is $37.4 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 34.67, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $37.4 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 17.89, creating a Buy signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Feb 21, 2025, 08:45 AM
Name
Value
Implied Action
RSI (14)
46.43
Neutral
STOCH (9,6)
19.48
Buy
STOCHRSI (14)
53.08
Neutral
MACD (12,26)
1.26
Sell
ADX (14)
20.93
Neutral
Williams %R
-56.90
Buy
CCI (14)
10.03
Neutral
ATR (14)
3.60
-
Ultimate Oscillator
51.52
Neutral
ROC
25.25
Buy
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 46.43, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 20.93, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is 10.03, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is 25.25, creating a Buy signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Sell.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 46.43, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is 1.26, which suggests DRUG is a Sell.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 41.52, which suggests DRUG is a Sell.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 37.60, which suggests DRUG is a Sell.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 38.11, which suggests DRUG is a Sell.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 17.89, which suggests DRUG is a Buy.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -56.90, which suggests DRUG is a Buy.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is 10.03, which suggests DRUG is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis